SLC38A4 and neoplasm: SLC38A4 was positively associated with ARG1 and EDNRB, while it was negatively associated with TNFSF4. ARG1 promotes tumor immune evasion by depleting L-arginine in the TME, leading to T cell dysfunction [55].